Sponsor:
UI Contact:
Updated Date:
The National Institutes of Health, through its NIH Guide, has recently published the following funding-related notices, program announcements, and requests for applications:
Notices
- Findings of Research Misconduct
National Institutes of Health - Findings of Research Misconduct
National Institutes of Health - NIH Implementation of the Final Rule on the Federal Policy for the Protection of Human Subjects (Common Rule)
National Institutes of Health - Notice of Intent to Publish a Funding Opportunity Announcement for INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Project
National Institutes of Health - Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071
National Institute on Aging - Notice to Specify High-Priority Research Topic for PAR-19-070 and PAR-19-071
National Institute on Aging - Notice of Changes to Award Information for RFA-AG-19-025 "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R43/R44 Clinical Trial Not Allowed)"
National Institute on Aging - Notice of Changes to Award Information for RFA-AG-19-026 "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (R41/R42 Clinical Trial Not Allowed)"
National Institute on Aging - Notice of Pre-Application Webinar Part II for RFA-AG-19-025 and RFA-AG-19-026, "Development of Personalized In Vitro Assays to Quantitatively Assess Age-related Changes in Cellular Resiliencies to Physiologic Stressors (SBIR/STTR)"
National Institute on Aging - NCCIH Policy for SBIR and STTR Phase I Applications Proposing Clinical Trials to the Omnibus Solicitations
National Center for Complementary and Integrative Health - Notice of 3 Pre-Application Webinars for NCCIH HEAL Funding Opportunity Announcements
National Center for Complementary and Integrative Health - Notice of Intent to Publish: Cellular Cancer Biology Imaging Research (CCBIR) Program (UM1 Clinical Trial Not Allowed)
National Cancer Institute - Notice of Correction to Application Types Allowed for RFA-DA-19-030, " Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)"
National Institute on Drug Abuse - Request for Proposals (RFP) Notice: Analytical Chemistry and Stability Testing of Treatment Drugs for Substance Use Disorders
National Institute on Drug Abuse - Notice of Expiration of PA-18-635 "NEI Academic Research Enhancement Award for Mechanistic and Minimal Risk Human Subjects' Research (R15 Clinical Trial Optional)"
National Eye Institute - Request for Information (RFI): NICHD Strategic Plan Fiscal Years 2020-2024
Eunice Kennedy Shriver National Institute of Child Health and Human Development - Notice of NIMHD Participation in PAR-19-134 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PAR-19-135 "Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-19-116, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Required)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-19-117, "Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Clinical Trial Not Allowed)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-19-118, Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Required)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-19-119, "Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Clinical Trial Not Allowed)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-19-126, "Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Not Allowed)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-19-127, "Mentored Research Scientist Development Award (Parent K01 - Independent Clinical Trial Required)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-19-129, "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Required)"
National Institute on Minority Health and Health Disparities - Notice of NIMHD Participation in PA-19-130, "NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)"
National Institute on Minority Health and Health Disparities - Notice of Change to Key Dates for RFA-NS-19-021 "HEAL Initiative: Pain Management Effectiveness Research Network: Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)"
National Institute of Neurological Disorders and Stroke
Requests for Applications
- Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R01 Clinical Trial Optional)
- Exploring the Mechanisms Underlying Analgesic Properties of Minor Cannabinoids and Terpenes (R21 Clinical Trial Optional)
National Center for Complementary and Integrative Health
- U.S.-China Program for Biomedical Collaborative Research (R01 Clinical Trial Optional)
National Cancer Institute
National Eye Institute
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
- Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R41/R42 - Clinical Trial Not Allowed)
- Analytical Tools and Approaches for (Multidimensional) Scholarly Research Assessment and Decision Support in the Biomedical Enterprise (R43/R44 - Clinical Trial Not Allowed)
National Institute on Drug Abuse
- Resources for Technology Dissemination (U24 Clinical Trial Not Allowed)
National Institute of Biomedical Imaging and Bioengineering.
Program Announcements
- NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
National Institute on Deafness and Other Communication Disorders - NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
- NIDCD Research Career Enhancement Award for Established Investigators (K18 Basic Experimental Studies with Humans Required)
National Institute on Deafness and Other Communication Disorders - ImmuneChip: Engineering Microphysiological Immune Tissue Platforms (U01 Clinical Trial Not Allowed)
National Institute of Biomedical Imaging and Bioengineering
National Center for Advancing Translational Sciences
National Institute of Arthritis and Musculoskeletal and Skin Diseases
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Basic Experimental Studies with Humans Required)
- NIDCR Dual Degree Dentist Scientist Pathway to Independence Award (K99/R00 Independent Clinical Trial Not Allowed)
National Institute of Dental and Craniofacial Research
Details, including application deadlines, when applicable, are available through the program links above. To view the full NIH Guide, present and/or past, please visit http://grants1.nih.gov/grants/guide/index.html
Members of the University of Iowa community may direct questions to the UI Division of Sponsored Programs at 335-2123, or email Lynn Hudachek at lynn-hudachek @uiowa.edu, or Erin Brothers at erin-brothers@uiowa.edu